(EMAILWIRE.COM, March 12, 2008 ) Calgary, AB – Calgary based Tech Avenue Ventures Corp. announced today that it has launched a commercial pilot program for its MPowRx anti-snoring appliance in participating dental clinics in Calgary, comprising a total patient population of approximately 25,000. The dental clinics participating in the MPowRx commercial pilot were selected for their demonstrated leadership in adopting innovative technologies.

Snoring and sleep apnea are all too common sleep disorders which carry serious medical and social consequences. Nearly 60 million people in North America suffer from problematic snoring or mild Obstructive Sleep Apnea (OSA), a condition in which patients stop breathing during sleep. The majority of sufferers (98 percent) simply ignore their condition or seek the convenience of over-the-counter remedies that lack clinical efficacy.

“This is a remarkable product,” says dentist Dr. Larry Stanleigh who is participating in the MPowRx commercial pilot program. “It addresses the concerns we have with other in-the-mouth devices, and at a price point that can be accessible to a large segment of the population that ordinarily would avoid trying anything. I believe this product has the potential to change some peoples’ lives, and/or the lives of the people they sleep with.” The MPowRx appliance is a novel first line treatment option that can be readily administered by dentists and sleep specialists as no special fitting is required, yet patients receive the benefit of diagnosis and oversight by a qualified health care practitioner. In addition to the clinic of Dr Larry Stanleigh, other participating clinics in the MPowRx commercial pilot program in Calgary include: Next Dimension Dentistry, Kearns, Hunt & Hrach and Alpha Dental Care.

“The response we have received from the Calgary dental clinics to our call for participation in the MPowRx commercial pilot program has been exceptionally strong,” says Gijs van Rooijen of Tech Avenue Ventures. “This clearly underscores the tremendous market potential for the MPowRx appliance.” The company expects to proceed with a full scale commercial launch of its MPowRx device later this year.

MPowRx is a trademark of Tech Avenue Ventures Corp. More information is available at www.mpowrx.com.

About Tech Avenue Ventures Corp.

Tech Avenue Ventures Corp, incorporated in December 2005 and based in Calgary, Alberta, is a venture development company focused on accelerating the commercialization of high value consumer and medical products. Tech Avenue Ventures is leveraging its life sciences management and core expertise in the areas of sales and marketing, research and development, manufacturing, and intellectual property to guide the development and commercialization process and build profitable companies. More information can be accessed at www.taventures.ca.

Business Contact: Gijs van Rooijen, Ph.D. Co-Founder
Tech Avenue Ventures Corp.
vanro@taventures.ca
403.671.4627

Media Contact: Rodger Roeser, APR
Eisen Management Group
rroeser@eisenmanagementgroup.com
859.586.4302

###

This press release was issued through GroupWeb EmailWire.Com. For more information on press release distribution, go to http://www.emailwire.com

Contact Information:
Tech Avenue Ventures
Allison Brinkman
Tel: 859.291.4302
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.